Review of regulation of biological and biotechnological products in Latin American and Caribbean countries-Reference-Cited by-同舟云学术

Review of regulation of biological and biotechnological products in Latin American and Caribbean countries

Published:2009-10 Issue:5 Volume:37 Page:271-276
ISSN:1045-1056
Container-title:Biologicals
language:en
Short-container-title:Biologicals

Author:

Pombo María L.,Di Fabio José L.,Cortés María de los A.

Publisher

Elsevier BV

Subject

Pharmacology,General Immunology and Microbiology,Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Reference30 articles.

1. World Health Organization. Training manual: licensing, lot release, laboratory access; 2001.

2. World Health Organization. Annex 1: good manufacturing practices for biological products. Geneva: WHO; 1992. Technical Report Series: 822.

3. World Health Organization [Homepage]. Geneva: The Organization; 2008 [cited on February 10th 2008]. Biologicals, Available from: http://who.int/biologicals/areas/en.

4. World Health Organization. Annex 2: guidelines for national authorities on quality assurance for biological products. Geneva: WHO; 1992. Technical Report Series: 822.

5. Organización Panamericana de la Salud. Módulos I y II: Vacunas de Calidad, Washington: OPS; 2004.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Substandard, falsified and unregistered medicines in Latin America, 2017-2018;Revista Panamericana de Salud Pública;2020-10-06

2. Efficacy and Safety in the Continued Treatment With a Biosimilar Drug in Patients Receiving Infliximab: A Systematic Review in the Context of Decision-Making From a Latin-American Country;Frontiers in Pharmacology;2019-11-15

3. Characterization and comparability of biosimilars: A filgrastim case of study and regulatory perspectives for Latin America;Electronic Journal of Biotechnology;2016-11

4. Characterization of production processes for tetanus and diphtheria anatoxins;Biologicals;2014-03

5. Review on the worldwide regulatory framework for biosimilars focusing on the Mexican case as an emerging market in Latin America;Biotechnology Advances;2013-12